99 related articles for article (PubMed ID: 34549500)
21. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community.
Niikawa H; Okamura T; Ito K; Ura C; Miyamae F; Sakuma N; Ijuin M; Inagaki H; Sugiyama M; Awata S
Geriatr Gerontol Int; 2017 Sep; 17(9):1286-1293. PubMed ID: 27628036
[TBL] [Abstract][Full Text] [Related]
22. Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of Acute Kidney Injury in Elderly Patients.
Chao CT; Tsai HB; Wu CY; Lin YF; Hsu NC; Chen JS; Hung KY
Medicine (Baltimore); 2015 Aug; 94(31):e1251. PubMed ID: 26252287
[TBL] [Abstract][Full Text] [Related]
23. The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls.
Zia A; Kamaruzzaman SB; Tan MP
Geriatr Gerontol Int; 2017 Mar; 17(3):463-470. PubMed ID: 26822931
[TBL] [Abstract][Full Text] [Related]
24. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Waite L; Seibel MJ; McLachlan AJ; Cumming RG; Handelsman DJ; Le Couteur DG
J Clin Epidemiol; 2012 Sep; 65(9):989-95. PubMed ID: 22742913
[TBL] [Abstract][Full Text] [Related]
25. Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial.
Lockery JE; Ernst ME; Broder JC; Orchard SG; Murray A; Nelson MR; Stocks NP; Wolfe R; Reid CM; Liew D; Woods RL;
Pharmacotherapy; 2020 Oct; 40(10):1042-1053. PubMed ID: 33078479
[TBL] [Abstract][Full Text] [Related]
26. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.
Payne RA; Abel GA; Avery AJ; Mercer SW; Roland MO
Br J Clin Pharmacol; 2014 Jun; 77(6):1073-82. PubMed ID: 24428591
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with polypharmacy in elderly home-care patients.
Komiya H; Umegaki H; Asai A; Kanda S; Maeda K; Shimojima T; Nomura H; Kuzuya M
Geriatr Gerontol Int; 2018 Jan; 18(1):33-41. PubMed ID: 28786554
[TBL] [Abstract][Full Text] [Related]
28. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study.
Sato I; Akazawa M
Drug Healthc Patient Saf; 2013; 5():143-50. PubMed ID: 23843704
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacy and prescribing quality in older people.
Steinman MA; Landefeld CS; Rosenthal GE; Berthenthal D; Sen S; Kaboli PJ
J Am Geriatr Soc; 2006 Oct; 54(10):1516-23. PubMed ID: 17038068
[TBL] [Abstract][Full Text] [Related]
30. Polypharmacy in elderly hospitalised patients in Slovakia.
Wawruch M; Zikavska M; Wsolova L; Kuzelova M; Tisonova J; Gajdosik J; Urbanek K; Kristova V
Pharm World Sci; 2008 Jun; 30(3):235-42. PubMed ID: 17943457
[TBL] [Abstract][Full Text] [Related]
31. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study.
Kim SJ; Kwon OD; Han EB; Lee CM; Oh SW; Joh HK; Oh B; Kwon H; Cho B; Choi HC
Medicine (Baltimore); 2019 Dec; 98(49):e17825. PubMed ID: 31804305
[TBL] [Abstract][Full Text] [Related]
32. Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K Antagonists.
Eggebrecht L; Nagler M; Göbel S; Lamparter H; Keller K; Wagner B; Panova-Noeva M; Ten Cate V; Bickel C; Lauterbach M; Espinola-Klein C; Hardt R; Münzel T; Prochaska JH; Wild PS
J Am Geriatr Soc; 2019 Mar; 67(3):463-470. PubMed ID: 30536652
[TBL] [Abstract][Full Text] [Related]
33. Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.
Zhang X; Zhou S; Li X; Zhou W; Zhou Y; Cui Y; Liu X
Int J Clin Pharm; 2019 Oct; 41(5):1152-1158. PubMed ID: 31392583
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Millenaar D; Schumacher H; Brueckmann M; Eikelboom JW; Ezekowitz M; Slawik J; Ewen S; Ukena C; Wallentin L; Connolly S; Yusuf S; Böhm M
Am J Cardiol; 2021 Jun; 149():27-35. PubMed ID: 33757788
[TBL] [Abstract][Full Text] [Related]
35. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT; Streit S; Lauffenburger JC
BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with potentially harmful drug-drug interactions in older Korean people: A population-based study.
Yoon SJ; Kim JS; Jung JG; Ahn SK; Song YS; Bae NK; Seon JY; Kim JH
Geriatr Gerontol Int; 2018 Sep; 18(9):1378-1382. PubMed ID: 30094910
[TBL] [Abstract][Full Text] [Related]
37. Number of medications or number of diseases: what influences underprescribing?
Gorup EC; Šter MP
Eur J Clin Pharmacol; 2017 Dec; 73(12):1673-1679. PubMed ID: 28920183
[TBL] [Abstract][Full Text] [Related]
38. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital.
Tefera YG; Alemayehu M; Mekonnen GB
PLoS One; 2020; 15(6):e0234000. PubMed ID: 32479516
[TBL] [Abstract][Full Text] [Related]
40. Polypharmacy and chronic pain: harm exposure is not all about the opioids.
Giummarra MJ; Gibson SJ; Allen AR; Pichler AS; Arnold CA
Pain Med; 2015 Mar; 16(3):472-9. PubMed ID: 25280054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
